Literature DB >> 9748471

Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein.

O Turunen1, M Sainio, J Jääskeläinen, O Carpén, A Vaheri.   

Abstract

Ezrin, radixin and moesin (ERM proteins) link cell adhesion molecules to the cytoskeleton, modulate cell morphology and cell growth and are involved in Rho-mediated signal transduction. Merlin, the tumor suppressor in neurofibromatosis 2, is a diverged member of the ezrin family, but its function is at least partially similar to the ERM proteins. In the N-domain, the ezrin family belongs to the band 4.1 superfamily. Secondary structure predictions made separately for the ezrin and band 4.1-tyrosine phosphatase families give a similar pattern for the homologous N-domains, indicating that both families have a similar binding site for the integral membrane proteins. The alpha-domain shows a strong coiled-coil prediction, that can be involved in the protein dimerization. The C-terminal actin-binding site in the ERM proteins and the actin-binding helix in the villin headpiece have a common amino acid motif. In merlin, the published tumor-associated single amino acid mutations in the N-domain are located in the conserved sites, and they affect mainly the predicted helices and strands, indicating that these mutations cause the disease primarily by disturbing the protein structure. In the alpha- and C-domains, some of the mutations break the helical structures. Some known mutations are observed at a site potentially interacting with cell adhesion molecules. We will also discuss the implications of the evolutionary information and the actin-binding models in the ezrin family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748471     DOI: 10.1016/s0167-4838(98)00103-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Self-masking in an intact ERM-merlin protein: an active role for the central alpha-helical domain.

Authors:  Qianzhi Li; Mark R Nance; Rima Kulikauskas; Kevin Nyberg; Richard Fehon; P Andrew Karplus; Anthony Bretscher; John J G Tesmer
Journal:  J Mol Biol       Date:  2006-10-26       Impact factor: 5.469

Review 2.  Cell-cell communication and axis specification in the Drosophila oocyte.

Authors:  John S Poulton; Wu-Min Deng
Journal:  Dev Biol       Date:  2007-08-22       Impact factor: 3.582

3.  Fluorescence resonance energy transfer analysis of merlin conformational changes.

Authors:  Robert F Hennigan; Lauren A Foster; Mary F Chaiken; Timmy Mani; Michelle M Gomes; Andrew B Herr; Wallace Ip
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

4.  Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.

Authors:  R P Stokowski; D R Cox
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

5.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 6.  Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

Authors:  Ivan Stamenkovic; Qin Yu
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

Review 7.  Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction.

Authors:  J A Girault; G Labesse; J P Mornon; I Callebaut
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

8.  Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.

Authors:  Kseniya Golovnina; Alexander Blinov; Elena M Akhmametyeva; Leonid V Omelyanchuk; Long-Sheng Chang
Journal:  BMC Evol Biol       Date:  2005-12-02       Impact factor: 3.260

9.  The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells.

Authors:  Bruce E Elliott; Jalna A Meens; Sandip K SenGupta; Daniel Louvard; Monique Arpin
Journal:  Breast Cancer Res       Date:  2005-03-21       Impact factor: 6.466

10.  Tissue-specific regulation by estrogen of ezrin and ezrin/radixin/moesin-binding protein 50.

Authors:  Perry M Smith; Ann Cowan; Sharon L Milgram; Bruce A White
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.